U.S. Residential REITs Stock News

Vaxcyte (NasdaqGS:PCVX) has launched a comprehensive Phase 3 adult clinical program for its VAX-31 pneumococcal conjugate vaccine. The company has completed enrollment in a Phase 2 study of VAX-31 in infants. Vaxcyte is preparing to advance a separate vaccine candidate targeting Group A Streptococcus. These moves follow FDA alignment and an expanded Breakthrough Therapy designation for VAX-31. Vaxcyte, trading at about $61.35, is moving into a more mature stage of its pipeline, with VAX-31...

Hertz Global Holdings (HTZ) has been on many investors’ watchlists after a mixed share price pattern, with a roughly 20% decline over the past month but a modest gain over the past year. See our latest analysis for Hertz Global Holdings. With the latest share price at $4.44, Hertz Global Holdings has seen momentum fade recently, with a 30-day share price return of 19.71% and a year-to-date share price return of 14.94%, even though the 1-year total shareholder return is 4.72% and the 3-year...

Why Hologic Stock Is Back on Investors’ Radar Hologic (HOLX) is drawing fresh attention after recent share price moves, prompting investors to reassess how its current valuation lines up with the company’s fundamentals and recent share performance. The stock last closed at US$75.35, with total return readings ranging from a small 1 day decline to a modest gain over the past 3 months and a stronger move over the past year. See our latest analysis for Hologic. For Hologic, a 1 year total...

If you are wondering whether Live Nation Entertainment's current share price lines up with its underlying value, you are not alone. Many investors are asking the same question right now. The stock last closed at US$157.98, with returns of 0.3% over the past week, 7.5% over the past month, 8.7% year to date and 9.4% over the past year, so it is understandable that investors want to know what is priced in. Recent headlines around Live Nation have continued to focus on the broader live events...

The CEO and a board director of Watts Water Technologies (NYSE:WTS) recently reported insider share sales within a short time frame. The company also disclosed several acquisitions focused on water management and control solutions. Management is committing capital to smart, connected product lines as part of its broader digital transformation efforts. Watts Water Technologies, traded on the NYSE under the ticker WTS, focuses on products that control the flow, safety, and quality of water in...

If you are wondering whether Woodward's current share price reflects its real worth, you are not alone. This article is built to help you frame that question clearly. Woodward's share price recently closed at US$394.76, with returns of 2.0% over 7 days, 20.7% over 30 days, 27.0% year to date, 116.8% over 1 year, 305.8% over 3 years and 247.4% over 5 years. This naturally raises questions about what is already priced in and what might still be at stake. Against this backdrop, the key story...

What recent performance tells you about Turning Point Brands (TPB) Turning Point Brands (TPB) has drawn attention after recent share price gains, with the stock up about 16% over the past month and roughly 38% in the past 3 months. See our latest analysis for Turning Point Brands. That recent momentum sits on top of a longer upswing, with Turning Point Brands’ share price return over the past year far outpaced by an even stronger one year total shareholder return, which includes dividends and...

Progress Software recently reported strong quarterly results, underpinned by recurring revenue from its subscription model, high‑margin infrastructure software, and the ahead‑of‑schedule integration of its largest acquisition, ShareFile. The addition of Nuclia’s agentic RAG technology and continued customer reliance on Progress’s mission‑critical products highlight how AI and acquisitions are becoming central to its business model. Next, we’ll explore how Progress Software’s early completion...

In February 2026, Procter & Gamble reported fiscal second-quarter adjusted earnings per share of US$1.88, slightly above consensus estimates, while revenue came in below forecasts, alongside continued product innovation across brands like Tide, Head & Shoulders, Cascade, Spruce and Zevo. This mix of earnings outperformance, active portfolio innovation and insider share sales by Chief Legal Officer Susan Street Whaley has prompted analysts to reassess Procter & Gamble’s resilience, capital...

OSI Systems, Inc. recently announced that its Security division’s Itemiser 4DX and new Itemiser 5X trace detection systems achieved ECAC/EU G1 approval, meeting the highest current European standards for aviation security and enabling use across airports, cargo screening, and other critical security settings. This certification strengthens OSI Systems’ position in regulated security markets by aligning its widely deployed trace detection platforms with the strictest European compliance...

If you are wondering whether Primo Brands at around US$19.36 is a bargain or a value trap, you are not alone. This article is designed to help you frame that question clearly. The stock has seen mixed returns, with a 5.9% move over the last 7 days, 0.5% over 30 days, 19.6% year to date, a 41.6% decline over 1 year, and gains of 36.6% and 48.2% over 3 and 5 years respectively. These figures can change how investors think about both upside and risk. Recent news coverage around Primo Brands has...

In February 2026, LiveRamp’s partners Scowtt and Canela Media each announced new collaborations that embed Scowtt’s predictive AI models into LiveRamp’s data collaboration platform and open LiveRamp’s network to Canela’s proprietary audience of over 30 million U.S. Hispanics. Together, these moves deepen LiveRamp’s role at the center of AI-driven advertising optimization while expanding access to culturally specific, first-party audience segments for marketers. We’ll examine how integrating...

Why Lincoln Educational Services (LINC) Is Catching Investor Attention Lincoln Educational Services (LINC) has drawn interest after a period of strong share price moves, with the stock showing solid returns over the past month, past 3 months and year. With the most recent close at $35.45 and annual revenue of $518.241 million alongside net income of $19.998 million, many investors are looking more closely at what is already priced into LINC. See our latest analysis for Lincoln Educational...

In February 2026, Herbalife Ltd. reported fourth-quarter 2025 sales of US$1,283.0 million and net income of US$85.4 million, issued 2026 net sales growth guidance, and announced plans to refinance up to US$1.55 billion of senior secured debt to extend its maturity profile. At the same time, Herbalife highlighted its push into personalized nutrition and digital health through its Pro2col platform, supported by a US$7.5 million investment and services commitment from Cristiano Ronaldo for a...

If you are wondering whether Teleflex is starting to look like value after a tough few years, this article will walk through what the current share price might be implying. The stock has risen 5.9% over the last 7 days and 8.4% over the last 30 days, although it remains down 8.4% year to date and 36.2% over 1 year, with a 51.8% 3 year and 71.3% 5 year decline. Recent coverage of Teleflex has largely focused on how the share price has pulled back over several years and what that means for...

If you are wondering whether Eli Lilly's current share price fairly reflects its long term potential, you are not alone. This article is designed to help you make sense of what you are paying for. The stock last closed at US$1,042.15, with returns of 0.6% over 7 days, a 2.1% decline over 30 days, a 3.5% decline year to date, and a 16.4% gain over the past year. The 3 year return sits at 242.4% and the 5 year return at 436.6%. Recent headlines around Eli Lilly have focused on its role in...

Oncolytics Biotech (ONCY) has attracted fresh attention after a recent move in its share price, with the stock closing at US$1.13 and showing mixed return patterns across the past year and over multiple years. See our latest analysis for Oncolytics Biotech. The recent 6.6% 1 day share price return and 10.8% 7 day share price return suggest short term momentum is building around Oncolytics Biotech, even as the 58.3% 1 year total shareholder return contrasts with weaker 3 and 5 year total...

New global tariffs announced by the Trump administration and weaker recent financial updates have put Crocs (CROX) in focus, as investors reconsider the stock in light of softer guidance and pressure on internationally reliant supply chains. See our latest analysis for Crocs. The mixed backdrop of tariff headlines, softer guidance and ongoing buybacks has coincided with a 12.65% 1 month share price return and 13.14% 3 month share price return. However, the 1 year total shareholder return of...

Preferred Bank reclassified a sizable loan relationship from substandard to nonaccrual status following ongoing legal complications involving the borrower’s principals. The borrower is facing complex lawsuits that have contributed to cash flow pressures and payment issues on the loan. Management has indicated that, based on current expectations, the ultimate resolution of this credit is not expected to significantly affect 2026 earnings. For you as an investor following NasdaqGS:PFBC, this...

Boise Cascade (BCC) has wrapped up FY 2025 with Q4 revenue of US$1.5 billion and basic EPS of US$0.24, alongside trailing twelve month revenue of US$6.4 billion and EPS of US$3.54 that frame the current run rate. The company has seen quarterly revenue range from US$1.5 billion to US$1.7 billion across 2025, with basic EPS moving from US$1.06 in Q1 and US$1.64 in Q2 to US$0.58 in Q3 and US$0.24 in Q4. This puts the spotlight squarely on how sustainably Boise Cascade can defend its margins from...

If you are wondering whether Generac Holdings at around US$235 per share is still reasonably priced or already stretched, you are not alone. The stock has returned 0.7% over the last 7 days, 35.9% over 30 days, 66.7% year to date, 69.5% over 1 year and 96.0% over 3 years, while the 5 year return sits at a 30.6% decline. These moves have come as investors continue to reassess Generac's role in the capital goods space. They are paying close attention to how its products fit into longer term...

Earlier in February 2026, Impinj reported its fourth-quarter and full-year 2025 results, highlighting record adjusted EBITDA margins and a 9% year-over-year increase in endpoint IC unit volumes driven by its M800 platform, while guiding first-quarter 2026 revenue to be roughly 2% lower year-over-year amid inventory normalization, retail softness, product obsolescence, and modest price reductions. Analyst commentary following these results, including concerns about extended channel inventory...

Curbline Properties Corp., a self-managed REIT trading under the symbol CURB, recently declared its first quarter 2026 common stock dividend of US$0.17 per share, a 6% increase from the fourth quarter 2025 payout, payable on April 8, 2026 to shareholders of record on March 18, 2026. This higher dividend highlights management’s willingness to return more cash to investors, which may be interpreted as confidence in the REIT’s ability to support its current payout level. We’ll now examine how...

CoreCivic (CXW) is back on investor radars after recent share price swings, with the stock up about 1.6% on the day but showing declines over the past week and month. See our latest analysis for CoreCivic. While the share price is around $16.47 today and up on the day, the 7 day and 30 day share price returns of 11.88% and 17.94% declines contrast with a much stronger 3 year and 5 year total shareholder return of 69.62% and 121.97%. This suggests longer term holders have seen very different...